Defining Mechanisms and Biomarkers of Sensitivity & Resistance To Anti-Cancer Treatments
Wednesday, December 9 from 10a.m-11:30a.m.
The discussion will highlight mechanisms of resistance to clinical applications, developing and applying biomarkers, and drug sensitivity, as well as addressing major challenges, such as:
- Identifying new targets for specific tumors
- Dissecting the complexity of drug resistance
- Reviewing systemic influences on tumors
- Pinpointing next gen biomarkers
Moderator: Barbara Burtness, MD, Professor of Medicine (Medical Oncology), Yale School of Medicine; Disease Aligned Research Team Leader, Head and Neck Cancers Program; Co-Leader, Developmental Therapeutics, Yale Cancer Center
Panelists from the Yale School of Medicine:
Register https://yale.zoom.us/webinar/register/WN_7M_gseXsQoSmU0kWyTQQLw
Event Information
Event Topic:
Defining Mechanisms and Biomarkers of Sensitivity & Resistance To Anti-Cancer Treatments
Event Description:
Date/Time:
Date(s) - 12/09/20
9:00 am - 10:30 am
Event Location:
Other: Webinar- requires registration
Event Details
Event Type